SCHEMBL1893374

SCHEMBL1893374

COc1ccc(C2C(C(=O)c3cccs3)=C(O)C(=O)N2CCN2CCOCC2)cc1OC

nearest known ligand 0.80

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.80
MEN1 O00255 6/20 0.80
ALOX15 P16050 2/20 0.73
MAPK1 P28482 1/20 0.73
ALDH1A1 P00352 10/20 0.65
KDM4E B2RXH2 6/20 0.65
MAPT P10636 5/20 0.64
LMNA P02545 2/20 0.64
SMN1; SMN2 Q16637 1/20 0.63
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
CASP1 P29466 1/20 0.62
CASP7 P55210 1/20 0.62
PPARG P37231 1/20 0.59
HSD17B10 Q99714 1/20 0.59
NCOR2 Q9Y618 1/20 0.59
RXFP1 Q9HBX9 2/20 0.58
HTT P42858 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12668751 0.84 ALDH1A1 (0.69) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL1896870 0.83 ALDH1A1 (0.86) KMT2AMEN1ALOX15ALDH1A1KDM4E
SCHEMBL1896961 0.83 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL30774076 0.83 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL1895455 0.83 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL12668772 0.82 ALDH1A1 (0.66) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL742397 0.75 ALDH1A1 (0.91) KMT2AMEN1ALOX15MAPK1ALDH1A1
SCHEMBL12668776 0.74 MEN1 (0.75) KMT2AMEN1ALOX15MAPK1ALDH1A1
SCHEMBL30774080 0.74 KMT2A (0.74) KMT2AMEN1ALOX15MAPK1ALDH1A1
SCHEMBL1900564 0.74 KMT2A (0.74) KMT2AMEN1ALOX15MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024037910-A1 SYK INHIBITORS FOR USE IN THE TREATMENT OF CANCER Institut National de la Santé et de la Recherche Médicale (FR) 2024-02-22 WO disclosed
US-9504676-B2 Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-11-29 US disclosed
US-9504676-B2 Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-11-29 US disclosed
US-9504676-B2 Molecules inhibiting a metabolic pathway involving the Syk protein tyrosine kinase and method for identifying said molecules CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2016-11-29 US disclosed
EP-2285366-B1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NAT RECH SCIENT (FR) 2015-02-25 EP disclosed
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-26 US disclosed
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-26 US disclosed
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-06-26 US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 US disclosed
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179679-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES SYK, BTK, TYRO3 KMT2A 1901/4885MEN1 4288/4885ALOX15 943/4885
US-20110112098-A1 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES SYK, BTK, TYRO3 KMT2A 1901/4885MEN1 4288/4885ALOX15 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.